TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Self-Stigma of Mental Illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stigma Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Determination
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Levels of circulating biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Diabetic Screening Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Degree of disability after stroke
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Readmission for worsening heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Final Decisional Conflict Scale Score - Values Clarity Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Final Decisional Conflict Scale Score - Support Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Final Decisional Conflict Scale Score - Uncertainty Sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Final Readiness to Make a Choice in Stage of Decision-Making Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Initiative and Sexual Communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Body composition: Fatmass and Fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evaluation of Galvanic Skin Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated thrombotic risk at admission measured with Padua score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Estimated thrombotic risk at admission measured with IMPROVE-VTE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Estimated hemorrhagic risk at admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of atrial fibrillation diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain VSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of face Swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trismus intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: number of patients with cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total number of RT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concentrations in fetal blood relative to EC50 of letermovir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of middle ear pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of middle ear compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of hearing quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-item Pediatric Anxiety Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of AF detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Drug discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Esophageal pressure (cmH2O)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diaphragmatic thickening fraction (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Feasibility (% success)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual analogue scale-VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constant Murley Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Airway resistance at 20Hz (R20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of Insomnia Severity Index (ISI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Fetal Lung Elastography Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Signal strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of valence, arousal, dominance in the Self Assessment Manikin System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean value of heart rate and heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electrodermal activity values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in glucose oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Preoperative hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Perinatal Post traumatic Stress Disorder Questionnaire-II
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hospitalization period for PEP
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction of bruxism activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pattern discrimination accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scene understanding performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Dose-Limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain as measured by the Brief Pain Inventory (BPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety as measured by the Self-Rating Anxiety Scale (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep as measured by the Pittsburg Sleep Quality Index (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Comparison of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Comparison of length of stay in ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of participants reporting suicidal ideation or behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Anti-Abeta antibody titers in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neural connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Most Bothersome Symptom
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liver fat proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement liver dysfunction progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adrenocortical Carcinoma (ACC)
Endpoint domain: Mortality/survival
Primary endpoint: Imaging tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak pressure distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful establishment of pancreatic patient-derived tumoroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional brain characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microstructural brain characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pre-interventional value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-RP treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Bladder filling status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sexual Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Peabody Developmental Motor Scale- 2nd edition (PDMS-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintenance of anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-admission rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major Adverse Kidney Events
Endpoint domain: Adverse events/effects
Primary endpoint: Confidence in driving electric wheelchair
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of guideline concordant care vs guideline discordant care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in circulating plasma nitrite (pg/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in brachial artery total shear rate (S-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in systolic blood pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: neuroinflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of TM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Diet recommendations (mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Physical activity recommendations (mean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintubation within 48 hours of extubation
Endpoint domain: Adverse events/effects
Primary endpoint: Characteristics of recipients' microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seven-day point prevalence abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DNA methylation age (DNAmAge)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age acceleration (AgeAcc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial DNA copy number (mtDNAcn)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle thickness of Rectus femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of life (SF 12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxyhemoglobin Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: morphine (PCA) consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Embryo number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Changes in intrinsic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in global cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in psychological assessment of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in DASS-depression detection rate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in DASS-anxiety detection rate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in DASS-stress detection rate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Insomnia Severity Index (ISI) questionnaire insomnia detection rate
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Suitability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Viability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of PP Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in skeletal muscle O2 diffusive conductance (Dm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tightness of the calf muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Colistin or CMS AUC changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perioperative acute kidney injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mu event related desynchronization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frontal theta synchronization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to first unplanned change of the index dressing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Movement of joints using PSFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-year disease free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Tolerated Dose (MTD) of IMM0306
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Change in 30 meters sprint (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in electromyographic activity during sprint (μ/v)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathology complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMT (Trail Making Test)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total Load Index (TLI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SARS-CoV-2 conversion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Alzheimer's Disease Comprehensive Rating Scale (iADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectal Mucosal IgG Concentrations Against N. Gonorrhoeae OMV Antigen Ng1291
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rectal Mucosal IgG Concentrations Against N. Gonorrhoeae OMV Antigen CNG20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical characteristics of chronic lymphocytic leukemia (CLL) patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hip Osteoarthritis Outcome Score for Joint Replacement (HOOS JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Injection-related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Invasion depth of early esophageal squamous cell carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 3D LAD mean dose vs 4D LAD mean dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) 0-2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EM flares on medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate of Morbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality Rate by Age Group
Endpoint domain: Mortality/survival
Primary endpoint: Average Length of Hospital Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Patient reported quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: total daily crying time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total daily agitation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Summative usability of CEREBO®
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percent of total body weight loss (%TBWL) after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients with a reduction in %TBWL of at least 10% at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder Voiding Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent/Caregiver reported stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent/Caregiver reported depression and anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent/Caregiver care engagement level
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Incidence of peri-operative respiratory adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change in vaginal microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Awareness of prolapse and repair
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants agreeing on Feasibility of Intervention Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nightingale Symptom Assessment Scale (N-SAS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychosocial Adjustment to Illness Scale (PAIS-SR) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients at biochemical target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot sensation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Yale-Brown Obsessive Compulsive Scale (YBOCs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in cleft scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Lactic Acid Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Jumping Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient experiences during dialysis initiation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Days at Home after surgery
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Prevalence of CKD-aP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of CKD-aP using the Visual Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of CKD-aP using the Verbal Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Kynurenine / Tryptophan ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity (true-positive rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity (true-negative rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent in AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Attitude towards vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of inborn errors of immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Forward motile sperm ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Safety and tolerability of Leucettinib-21
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive flexibility Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Experiences Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Skeletal Muscle Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Complete virologic response (CVR) at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Tendon Diameter at the Place of Maximum Tendon Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Blood potassium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of clinically significant bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Residual beta cell mass and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Bone Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes